South Korean Pharmaceuticals & Biotech Sustainable Track Record

Results

1 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

5 companies

JW Holdings

Market Cap: ₩228.2b

Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.

A096760

₩3,410.00

6.1%

16.2%

JW Lifescience

Market Cap: ₩185.4b

Provides national infusion solutions in South Korea and internationally.

A234080

₩12,100.00

2.4%

0.7%

L&C BIOLTD

Market Cap: ₩624.7b

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

A290650

₩26,950.00

-7.5%

39.0%

ALTEOGEN

Market Cap: ₩17.8t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩333,500.00

2.3%

83.1%

Jin Yang Pharmaceutical

Market Cap: ₩75.4b

Engages in the pharmaceutical business in South Korea.

A007370

₩6,400.00

26.5%